PDF icon PDF herunterladen
Int J Angiol 2018; 27(03): 121-131
DOI: 10.1055/s-0036-1572523
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes

Anthony Paulo Sunjaya
1   Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
,
Angela Felicia Sunjaya
1   Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
,
Samuel Halim
2   Department of Internal Medicine, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
,
Frans Ferdinal
3   Department of Biochemistry, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
18. Februar 2016 (online)

   Lizenzen und Reprints
Preview

Abstract

Worldwide statins are considered to be the first-line pharmacological treatment for dyslipidemia and reducing the risk of coronary heart disease. However, recently various studies have shown its adverse effect on glucose control among diabetic patients and the U.S. Food and Drug Administration have revised statin drug labels to include information that increases in fasting serum glucose and glycated hemoglobin levels have been reported. This systematic review objective is to evaluate the risks and benefits of statins in glucose control management of type 2 diabetes patients based on the 44 published journal articles included and obtained through MEDLINE full text, PubMed, Science Direct, Pro Quest, SAGE, Taylor and Francis Online, Google Scholar, High Wire, and Elsevier Clinical Key. Statins were found to affect glucose control through several ways, namely, by affecting insulin production and secretion by β-pancreatic cells, insulin resistance, insulin uptake by the muscles and adipocytes and production of adipokines. Current evidence available shows that most of the statins give unfavorable side effects with regards to glucose control among diabetic patients. A dose-dependent and time-dependent effect was also observed in some statins which may be present among other statins as well.

Keywords

statins - glucose control - diabetes - hypercholesterolemia - insulin secretion - insulin sensitivity - insulin resistance